Haig P. Bozigian

2015

In 2015, Haig P. Bozigian earned a total compensation of $2.4M as Chief Development Officer at Neurocrine Biosciences, a 30% decrease compared to previous year.

Compensation breakdown

Bonus$190,800
Option Awards$1,397,500
Salary$381,600
Stock Awards$362,890
Other$39,024
Total$2,371,814

Bozigian received $1.4M in option awards, accounting for 59% of the total pay in 2015.

Bozigian also received $190.8K in bonus, $381.6K in salary, $362.9K in stock awards and $39K in other compensation.

Rankings

In 2015, Haig P. Bozigian's compensation ranked 4,047th out of 13,638 executives tracked by ExecPay. In other words, Bozigian earned more than 70.3% of executives.

ClassificationRankingPercentile
All
4,047
out of 13,638
70th
Division
Manufacturing
1,472
out of 5,187
72nd
Major group
Chemicals And Allied Products
538
out of 1,857
71st
Industry group
Drugs
426
out of 1,531
72nd
Industry
Biological Products, Except Diagnostic Substances
74
out of 260
72nd
Source: SEC filing on April 20, 2017.

Bozigian's colleagues

We found four more compensation records of executives who worked with Haig P. Bozigian at Neurocrine Biosciences in 2015.

2015

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2015

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2015

Timothy Coughlin

Neurocrine Biosciences

Chief Financial Officer

2015

Christopher O'Brien

Neurocrine Biosciences

Chief Medical Officer

News

In-depth

You may also like